Once-yearly zoledronic acid and days of disability, bed rest, and back pain: randomized, controlled HORIZON Pivotal Fracture Trial.

Cauley, JA; Black, D; Boonen, S; Cummings, SR; Mesenbrink, P; Palermo, L; Man, Z; Hadji, P; Reid, IR; HORIZON, Pivotal Fracture Group (2011). Once-yearly zoledronic acid and days of disability, bed rest, and back pain: randomized, controlled HORIZON Pivotal Fracture Trial. Journal of bone and mineral research, 26(5), pp. 984-992. Hoboken, N.J.: Wiley-Blackwell 10.1002/jbmr.292

Full text not available from this repository.

Item Type:	Journal Article (Original Article)
Division/Institute:	04 Faculty of Medicine > Department of Orthopaedic, Plastic and Hand Surgery (DOPH) > Clinic of Osteoporosis
UniBE Contributor:	Lippuner, Kurt
ISSN:	0884-0431
Publisher:	Wiley-Blackwell
Submitter:	Factscience Import
Date Deposited:	04 Oct 2013 14:23
Last Modified:	05 Dec 2022 14:06
Publisher DOI:	10.1002/jbmr.292
Web of Science ID:	000290486800011
URI:	https://boris.unibe.ch/id/eprint/8084 (FactScience: 213550)